The data showed a trend of dose-dependent reduction in mortality, although it was not statistically significant.
← all excerpts
The Clinical Impact of β-Blocker Therapy on Patients With Chronic Coronary Artery Disease After Percutaneous Coronary Intervention.
1
—
—